Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy. - Wikidata - awgldk - TriplyDB

Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.

Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.

http://www.wikidata.org/entity/Q44229422

about

Early feasibility testing and engineering development of a sutureless beating heart connector for left ventricular assist devices.Left ventricular assist devices-current state and perspectives Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.Is This Time Different? The Slowdown in Health Care Spending.Visualization and dynamics of multidimensional health-related quality-of-life-adjusted overall survival: a new analytic approach.The impact of insurance and socioeconomic status on outcomes for patients with left ventricular assist devices The cost-utility of left ventricular assist devices for end-stage heart failure patients ineligible for cardiac transplantation: a systematic review and critical appraisal of economic evaluations Ventricular assist device use in congenital heart disease with a comparison to heart transplant Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.Psychosocial characteristics and outcomes in patients with left ventricular assist device implanted as destination therapy Hospital costs fell as numbers of LVADs were increasing: experiences from Oslo University Hospital.Management of advanced heart failure in the elderly: ethics, economics, and resource allocation in the technological era Ventricular assist devices: is destination therapy a viable alternative in the non-transplant candidate?Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes Contemporary strategies in the diagnosis and management of heart failure Reading a cost-effectiveness or decision analysis study: Five things to consider.Frailty and the selection of patients for destination therapy left ventricular assist device Frailty and outcomes after implantation of left ventricular assist device as destination therapy Ethical considerations related to the use of mechanical support in congenital heart disease.Left ventricular assist devices: an evolving journey.Health economics of percutaneous hemodynamic support in the treatment of high-risk cardiac patients: a systematic appraisal of the literature.The Price of a Helping Hand: Modeling the Outcomes and Costs of Bystander CPR.Cost-effectiveness of left ventricular assist devices for patients with end-stage heart failure: analysis of the French hospital discharge database.Future Prospects for the Total Artificial Heart.Patient Selection for Long-Term Mechanical Circulatory Support: Is It Ever too Early for the NYHA Class III Patient?Left ventricular assist device: a bridge to transplant or destination therapy?Current status of mechanical circulatory support for treatment of advanced end-stage heart failure: successes, shortcomings and needs.An updated review of cardiac devices in heart failure.Cost-Effectiveness of Remote Cardiac Monitoring With the CardioMEMS Heart Failure System.VAD therapy 20/20: moving beyond the myopic view of a nascent therapy.Percutaneous cardiac assist devices compared with surgical hemodynamic support alternatives: cost-effectiveness in the emergent setting.Renal risk stratification in left ventricular assist device therapy.Cost-effectiveness of continuous-flow left ventricular assist devices.Cost of 1-year left ventricular assist device destination therapy in chronic heart failure: a comparison with heart transplantation.

P2860

Q27316011-5CAF9615-C8B7-4753-AD2A-00A84F3B0425 Q28074655-6F8F5551-E972-401E-9466-3F3C102CE7B1 Q28075310-FDEE7112-EB6C-4F8B-8312-3C30F5E4F8B6 Q30415071-2602C65B-5DB9-4410-B808-3911AA03588F Q30599528-B203CA48-0415-4319-85CA-E047BA679590 Q33656552-C8B9577E-DE4F-4CD3-BC70-0783C0E7EBD5 Q34160865-47CEA422-47AC-4518-A217-A534A2A2E2EA Q34498767-EDCA3D8C-0718-4EDC-A3EA-6DDB585E4AB9 Q34510391-4D1C6498-8D82-4421-AB83-FB955F04ED4D Q36116040-3BB861FB-96C1-4D2E-8C54-04321979065D Q36258969-E4D4475F-8DBA-48CF-9A0A-B7E05B6201AF Q36448422-B2DAAFB4-B19B-48DE-AA0C-34E9C1B3AAAD Q36464295-F47476A8-1E10-4674-BADA-F53631A7309C Q36597965-321BAE82-0363-4BF1-A6BB-DEB977423BE9 Q36776529-7901C93A-80DE-45F1-926E-519EC334E286 Q37041145-C762D89A-0001-4DE1-ADB2-6D9B68A9B5C7 Q37251702-A5C5F495-ECF1-49DE-A2A3-95D6C35EA891 Q37407820-EBF4F196-428F-46DC-852D-606EB3F6CF1F Q37666008-21BD6955-E3AC-4E4E-AB84-15EECD420486 Q38116950-0FCE7527-960F-4080-9292-E63C2576D68F Q38128910-991D4750-6ABE-4218-BD6D-9D7FAEC528B6 Q38204771-1FB616B5-32A9-40E4-8A9C-ED3DEF8D5083 Q38349201-EF9D4EB5-AD98-46F5-88E4-CEDC40A10EE1 Q38662720-9DF486CD-84D1-483E-8235-7A737474E907 Q38687232-8D3F07E1-C5EA-4D0F-AE96-0928E0273364 Q38701412-25DD27CA-4F57-4740-8FC7-B34E773C0707 Q38771063-70A0D619-5AF4-4CD2-A3BA-9982FECFB00A Q38870760-52033BF9-308B-485F-A66E-46D8B5883CB3 Q38876024-EB036002-1C62-4EA1-AC3E-A4725C02A45C Q38921111-CF97D00C-82C8-4C7D-9764-C8C16DA6279E Q42251472-5A7F2CA3-641C-4A11-A0AF-04AFF77ADA66 Q43802600-526C016B-71D0-40D2-AC20-045DFDFA166C Q47239698-30A6803E-2A3D-401B-A35D-3F454F78182E Q50803712-E33EFD47-3F80-4900-94B9-933B52FC1EC1 Q53552910-4F082A61-0A50-4510-8CE8-1F2B73EF390C

P2860

Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.

http://www.wikidata.org/entity/Q44229422

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Cost-effectiveness analysis of ...... evices as destination therapy.

@en

Cost-effectiveness analysis of ...... evices as destination therapy.

@nl

type

label

Cost-effectiveness analysis of ...... evices as destination therapy.

@en

Cost-effectiveness analysis of ...... evices as destination therapy.

@nl

prefLabel

Cost-effectiveness analysis of ...... evices as destination therapy.

@en

Cost-effectiveness analysis of ...... evices as destination therapy.

@nl

P1433

Q44229422-742B2F1E-1E50-4F14-8873-63F211BB2836

P1476

Q44229422-D9AF58C7-8CB9-4334-8B6E-3F3AEBF8C199

P2093

Q44229422-241AA4EC-B22A-4202-9F0E-C219126CAE8C

Q44229422-6B218B6D-C643-4461-B68B-0240BD3B4FD3

Q44229422-77DA4915-6A78-4DDB-B83A-7D0865D8BC89

Q44229422-8144D0A5-9ED0-410A-86C0-43D56A702C00

Q44229422-8B32321E-8B43-44F2-975F-A7BC4D28D6DE

Q44229422-931F08D0-A6EB-4587-B70B-662843D09F40

P304

Q44229422-6FD06FC2-97DA-4D04-B8B0-8E187B497A7A

P31

Q44229422-B8654D7F-7F0D-4E44-AE9B-762C5B29BC72

P356

Q44229422-9138D526-C809-4348-B5B5-971647031760

P433

Q44229422-498A1F8C-5222-4414-93A1-AC8ABA6D0B66

P478

Q44229422-F102AC16-548B-4360-B392-EFBB48AA7EEC

P577

Q44229422-94C13864-772E-4246-919C-FA9DCD823118

P698

Q44229422-CAA519FF-432F-4B8C-A0D4-E90D5BD41200

P356

CIRCHEARTFAILURE.111.962951

P1433

Circulation: Heart Failure

P1476

Cost-effectiveness analysis of ...... evices as destination therapy.

@en

P2093

Joseph G Rogers

http://www.w3.org/2001/XMLSchema#string

Kuo B Tong

http://www.w3.org/2001/XMLSchema#string

Mark Russo

http://www.w3.org/2001/XMLSchema#string

Mark S Slaughter

http://www.w3.org/2001/XMLSchema#string

Rob Adamson

http://www.w3.org/2001/XMLSchema#string

Robin R Bostic

http://www.w3.org/2001/XMLSchema#string

P304

10-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCHEARTFAILURE.111.962951

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22052901

http://www.w3.org/2001/XMLSchema#string